Model input | Base case value | Distribution |
---|---|---|
Transition probabilities | ||
W to S | 0.097 | β(SD: 0.029) |
W to A | 0.004 | β(SD: 0.002) |
S to W | 0.817 | β(SD: 0.038) |
S to A | 0.007 | β(SD: 0.003) |
A to W | 0.271 | β(SD: 0.044) |
A to S | 0.052 | β(SD: 0.046) |
Utility | ||
Well-controlled | 0.99 | β(SD: 0.016) |
Sub-optimal control | 0.70 | β(SD: 0.072) |
Asthma exacerbation | 0.31 | β(SD: 0.070) |
EO effectiveness | ||
Relative risk of reduction of exacerbations | 0.57 | LogN(SD: 0.20) |
FeNO-SC effectiveness | ||
Relative risk of reduction of exacerbations | 0.76 | LogN(SD: 0.274) |